Русская версия English version   
Том 21   Выпуск 2   Год 2026
Список литературы

  1. Folkman J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 1971;285(21):1182–1186. doi: 10.1056/NEJM197111182852108
  2. Jain R.K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 2005;307(5706):58–62. doi: 10.1126/science.1104819
  3. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nature Medicine. 2003;9(6):669–676. doi: 10.1038/nm0603-669
  4. Hicklin D.J., Ellis L.M. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. Journal of Clinical Oncology. 2005;23(5):1011–1027. doi: 10.1200/JCO.2005.06.081
  5. Nambigari N. Cancer therapeutics: structure-based drug design of inhibitors for a novel angiogenic growth factor. Math. Bioinformat. 2023. V.18. №1:72–88. doi: 10.17537/2023.18.72
  6. Anderson A.R.A., Chaplain M.A.J. Continuous and discrete mathematical models of tumor-induced angiogenesis. Bulletin of Mathematical Biology. 1998;60(5):857–899. doi: 10.1006/bulm.1998.0042
  7. Stephanou A., McDougall S.R., Anderson A.R., Chaplain M.A. Mathematical modelling of flow in 2D and 3D vascular networks: applications to anti-angiogenic and chemotherapeutic drug strategies. Mathematical and Computer Modelling. 2005;41(10):1137–1156. doi: 10.1016/j.mcm.2005.05.008
  8. Stéphanou A., McDougall S.R., Anderson A.R.A., Chaplain M.A.J. Mathematical modelling of the influence of blood rheological properties upon adaptative tumour-induced angiogenesis. Mathematical and Computer Modelling. 2006;44(1–2):96–123. doi: 10.1016/j.mcm.2004.07.021
  9. McDougall S.R., Anderson A.R.A., Chaplain M.A.J. Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies. Journal of Theoretical Biology. 2006;241(3):564–589. doi: 10.1016/j.jtbi.2005.12.022
  10. McDougall S.R., Chaplain M.A., Stéphanou A., Anderson A.R. Modelling the impact of pericyte migration and coverage of vessels on the efficacy of vascular disrupting agents. Mathematical Modelling of Natural Phenomena. 2010;5(1):163–202. doi: 10.1051/mmnp/20105108
  11. Wu J., Xu S., Long Q., Collins M.W., König C.S., Zhao G., Padhani A.R. Coupled modeling of blood perfusion in intravascular, interstitial spaces in tumor microvasculature. Journal of Biomechanics. 2008;41(5):996–1004. doi: 10.1016/j.jbiomech.2007.12.008
  12. Wu J., Long Q., Xu S., Padhani A.R. Study of tumor blood perfusion and its variation due to vascular normalization by anti-angiogenic therapy based on 3D angiogenic microvasculature. Journal of Biomechanics. 2009;42(6):712–721. doi: 10.1016/j.jbiomech.2009.01.009
  13. Alarcón T., Byrne H.M., Maini P.K. A cellular automaton model for tumour growth in inhomogeneous environment. Journal of Theoretical Biology. 2003;225(2):257–274. doi: 10.1016/S0022-5193(03)00244-3
  14. Cristini V., Lowengrub J., Nie Q. Nonlinear simulation of tumor growth. Journal of Mathematical Biology. 2003;46(3):191–224. doi: 10.1007/s00285-002-0174-6
  15. Anderson A.R.A. A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion. Mathematical Medicine and Biology: a Journal of the IMA. 2005;22(2):163–186. doi: 10.1093/imammb/dqi005
  16. Araujo R.P., McElwain D.L.S. A mixture theory for the genesis of residual stresses in growing tissues II: solutions to the biphasic equations for a multicell spheroid. SIAM Journal on Applied Mathematics. 2005;66(2):447–467. doi: 10.1137/040607125
  17. Jiang Y., Pjesivac-Grbovic J., Cantrell C., Freyer J.P. A multiscale model for avascular tumor growth. Biophysical Journal. 2005;89(6):3884–3894. doi: 10.1529/biophysj.105.060640
  18. Anderson A.R., Weaver A.M., Cummings P.T., Quaranta V. Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell. 2006;127(5):905–915. doi: 10.1016/j.cell.2006.09.042
  19. Yegorov I.Ye. Optimal Feedback Control in a Mathematical Model of Malignant Tumour Treatment with the Immune Reaction Taken Into Account. Маthematical Biology and Bioinformatics. 2014;9(1):257–272. doi: 10.17537/2014.9.257
  20. Macklin P., Lowengrub J. Nonlinear simulation of the effect of microenvironment on tumor growth. Journal of Theoretical Biology. 2007;245(4):677–704. doi: 10.1016/j.jtbi.2006.12.004
  21. Delsanto P.P., Condat C.A., Pugno N., Gliozzi A.S., Griffa M. A multilevel approach to cancer growth modeling. Journal of Theoretical Biology. 2008;250(1):16–24. doi: 10.1016/j.jtbi.2007.09.023
  22. Zhang L., Strouthos C.G., Wang Z., Deisboeck T.S. Simulating brain tumor heterogeneity with a multiscale agent-based model: linking molecular signatures, phenotypes and expansion rate. Mathematical and Computer Modelling. 2009;49(1–2):307–319. doi: 10.1016/j.mcm.2008.05.011
  23. Gerlee P., Anderson A.R.A. Evolution of cell motility in an individual-based model of tumour growth. Journal of Theoretical Biology. 2009;259(1):67–83. doi: 10.1016/j.jtbi.2009.03.005
  24. Zheng X., Wise S.M., Cristini V. Nonlinear simulation of tumor necrosis, neo-vascularization and tissue invasion via an adaptive finite-element/level-set method. Bulletin of Mathematical Biology. 2005;67(2):211–259. doi: 10.1016/j.bulm.2004.08.001
  25. Hogea C.S., Murray B.T., Sethian J.A. Simulating complex tumor dynamics from avascular to vascular growth using a general level-set method. Journal of Mathematical Biology. 2006;53(2):86–134. doi: 10.1007/s00285-006-0378-2
  26. Wise S.M., Lowengrub J.S., Frieboes H.B., Cristini V. Three-dimensional multispecies nonlinear tumor growth–I: model and numerical method. Journal of Theoretical Biology. 2008;253(3):524–543. doi: 10.1016/j.jtbi.2008.03.027
  27. Frieboes H.B., Jin F., Chuang Y.L., Wise S.M., Lowengrub J.S., Cristini V. Three-dimensional multispecies nonlinear tumor growth—II: tumor invasion and angiogenesis. Journal of Theoretical Biology. 2010;264(4):1254–1278. doi: 10.1016/j.jtbi.2010.02.036
  28. Alarcón T., Owen M.R., Byrne H.M., Maini P.K. Multiscale modelling of tumour growth and therapy: the influence of vessel normalisation on chemotherapy. Computational and Mathematical Methods in Medicine. 2006;7(2–3):85–119. doi: 10.1080/10273660600968994
  29. Owen M.R., Alarcón T., Maini P.K., Byrne H.M. Angiogenesis and vascular remodelling in normal and cancerous tissues. Journal of Mathematical Biology. 2009;58(4):689–721. doi: 10.1007/s00285-008-0213-z
  30. Bartha K., Rieger H. Vascular network remodeling via vessel cooption, regression and growth in tumors. Journal of Theoretical Biology. 2006;241(4):903–918. doi: 10.1016/j.jtbi.2006.01.022
  31. Lee D.S., Rieger H., Bartha K. Flow correlated percolation during vascular remodeling in growing tumors. Physical Review Letters. 2006;96(5). Article No. 058104. doi: 10.1103/PhysRevLett.96.058104
  32. Welter M., Rieger H. Physical determinants of vascular network remodeling during tumor growth. The European Physical Journal E. 2010;33(2):149–163. doi: 10.1140/epje/i2010-10611-6
  33. Welter M., Bartha K., Rieger H. Emergent vascular network inhomogeneities and resulting blood flow patterns in a growing tumor. Journal of Theoretical Biology. 2008;250(2):257–280. doi: 10.1016/j.jtbi.2007.09.031
  34. Jain R.K., Tong R.T., Munn L.L. Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. Cancer Research. 2007;67(6):2729–2735. doi: 10.1158/0008-5472.CAN-06-4102
  35. Zaitseva N.V., Kiryanov D.A., Lanin D.V., Chigvintsev V.M. A mathematical model of the immune and neuroendocrine systems mutual regulation under the technogenic chemical factors impact. Comput. Math. Methods Med. 2014;2014(1). Article No. 492489. doi: 10.1155/2014/492489
  36. Mukherjee A., Madamsetty V.S., Paul M.K., Mukherjee S. Recent advancements of nanomedicine towards antiangiogenic therapy in cancer. International Journal of Molecular Sciences. 2020;21(2). Article No. 455. doi: 10.3390/ijms21020455
  37. Lopes-Coelho F., Martins F., Pereira S.A., Serpa J. Anti-angiogenic therapy: current challenges and future perspectives. International Journal of Molecular Sciences. 2021;22(7). Article No. 3765. doi: 10.3390/ijms22073765
  38. Jiang X., Wang J., Deng X., Xiong F., Zhang S., Gong Z. Xiong W. The role of microenvironment in tumor angiogenesis. Journal of Experimental & Clinical Cancer Research. 2020;39(1):1–19. doi: 10.1186/s12943-018-0928-4
  39. Melincovici C.S., Boşca A.B., Şuşman S., Mărginean M., Mihu C., Istrate M. Mihu C.M. Vascular endothelial growth factor (VEGF)-key factor in normal and pathological angiogenesis. Rom. J. Morphol. Embryol. 2018;59(2):455–467.
  40. Bates D.O. Vascular endothelial growth factors and vascular permeability. Cardiovascular Research. 2010;87(2):262–271. doi: 10.1093/cvr/cvq105
  41. Boersma B., Jiskoot W., Lowe P., Bourquin C. The interleukin-1 cytokine family members: Role in cancer pathogenesis and potential therapeutic applications in cancer immunotherapy. Cytokine & Growth Factor Reviews. 2021;62:1–14. doi: 10.1016/j.cytogfr.2021.09.004
  42. Bairagi N., Chatterjee S., Chattopadhyay J. Variability in the secretion of corticotropin-releasing hormone, adrenocorticotropic hormone and cortisol and understandability of the hypothalamic-pituitary-adrenal axis dynamics – a mathematical study based on clinical evidence. Mathematical Medicine and Biology. 2008;25(1):37–63. doi: 10.1093/imammb/dqn003
  43. Kerdiles Y., Ugolini S., Vivier E. T cell regulation of natural killer cells. The Journal of Experimental Medicine. 2013;210(6):1065–1068. doi: 10.1084/jem.20130960
  44. Balkhi M.Y., Ma Q., Ahmad S., Junghans R.P. T cell exhaustion and Interleukin 2 downregulation. Cytokine. 2015;71(2):339–347. doi: 10.1016/j.cyto.2014.11.024
  45. Boyman O., Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nature Reviews Immunology. 2012;12(3):180–190. doi: 10.1038/nri3156
  46. Marchuk G.I., Petrov R.V., Romanyukha A.A., Bocharov G.A. Mathematical model of antiviral immune response. I. Data analysis, generalized picture construction and parameters evaluation for hepatitis B. Journal of Theoretical Biology. 1991;151(1):1–40. doi: 10.1016/S0022-5193(05)80142-0
  47. Demas G.E., Adamo S.A., French S.S. Neuroendocrine-immune crosstalk in vertebrates and invertebrates: Implications for host defence. Functional Ecology. 2011;25(1):29–39. doi: 10.1111/j.1365-2435.2010.01738.x
  48. Oh P.J., Jang E. Effects of psychosocial interventions on cortisol and immune parameters in patients with cancer: A meta-analysis. Journal of Korean Academy of Nursing. 2014;44(4):446–457. doi: 10.4040/jkan.2014.44.4.446
  49. Chigvintsev V.M., Trusov P.V., Zaitseva N.V. Mathematical model of antitumor immune response of organism regulation. AIP Conference Proceedings. AIP Publishing LLC, 2021;2371(1). Article No. 060001. doi: 10.1063/5.0059532
  50. Trusov P.V., Zaitseva N.V., Chigvintsev V.М. Predicting a risk of tumor evolution considering regulatory mechanisms of the body and angiogenesis. Health Risk Analysis. 2023(4):134–145. doi: 10.21668/health.risk/2023.4.13.eng
  51. Buyan M.I., Andrianova N.V., Popkov V.A., Zorova L.D., Pevzner I.B., Silachev D.N., Zorov D.B., Plotnikov E.Y. Age-Associated Loss in Renal Nestin-Positive Progenitor Cells. International Journal of Molecular Sciences. 2022;23(19). Article No. 11015. doi: 10.3390/ijms231911015
  52. Vollmers H.P., Brändlein S. Natural antibodies and cancer. New Biotechnology. 2009;25(5):294–298. doi: 10.1016/j.nbt.2009.03.016
  53. Perl A.J., Schuh M.P., Kopan R. Regulation of nephron progenitor cell lifespan and nephron endowment. Nature Reviews Nephrology. 2022;18(11):683–695. doi: 10.1038/s41581-022-00620-w
  54. Mahasa K.J., Ouifki R., Eladdadi A., de Pillis L. Mathematical model of tumor–immune surveillance. Journal of Theoretical Biology. 2016;404:312–330. doi: 10.1016/j.jtbi.2016.06.012
  55. Mendoza-Juez B., Martínez-González A., Calvo G.F., Pérez-García V.M. A mathematical model for the glucose-lactate metabolism of in vitro cancer cells. Bulletin of Mathematical Biology. 2012;74(5):1125–1142. doi: 10.1007/s11538-011-9711-z
  56. Plank M.J., Sleeman B.D., Jones P.F. A mathematical model of tumour angiogenesis, regulated by vascular endothelial growth factor and the angiopoietins. Journal of Theoretical Biology. 2004;229(4):435–454. doi: 10.1016/j.jtbi.2004.04.012
  57. Vilanova G., Colominas I., Gomez H. A mathematical model of tumour angiogenesis: growth, regression and regrowth. Journal of the Royal Society Interface. 2017;14(126). Article No. 20160918. doi: 10.1098/rsif.2016.0918
  58. Hanahan D., Weinberg R. A. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi: 10.1016/j.cell.2011.02.013
  59. Greaves M., Maley C.C. Clonal evolution in cancer. Nature. 2012;481(7381):306–313. doi: 10.1038/nature10762
  60. Carmeliet P., Jain R.K. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011;473(7347):298–307. doi: 10.1038/nature10144
  61. Sharonov G.V., Serebrovskaya, E.O., Yuzhakova D.V., Britanova O.V., Chudakov D.M. B cells, plasma cells and antibody repertoires in the tumour microenvironment. Nature Reviews Immunology. 2020;20(5):294–307. doi: 10.1038/s41577-019-0257-x
  62. Haus E., Smolensky M.H. Biologic rhythms in the immune system. Chronobiology International. 1999;16(5):581–622. doi: 10.3109/07420529908998730
  63. Pol J.G., Caudana P., Paillet J., Piaggio E., Kroemer G. Effects of interleukin-2 in immunostimulation and immunosuppression. Journal of Experimental Medicine. 2020;217(1). Article No. e20191247. doi: 10.1084/jem.20191247
Содержание Оригинальная статья
Трусов П.В., Зайцева Н.В., Чигвинцев В.М. Модель для изучения динамики опухолевого роста в контексте регуляторных процессов организма и механизмов ангиогенеза. Математическая биология и биоинформатика. 2026;21(2):332-352. doi: 10.17537/2026.21.332
(опубликована на рус. яз.)

Аннотация (рус.)
Аннотация (англ.)
Полный текст (рус., pdf)
Список литературы

 

  Copyright ИМПБ РАН © 2005-2026